ALTEOGEN Market Cap

ALTEOGEN has a market cap or net worth of 23.89 trillion as of September 26, 2025. Its market cap has increased by 42.52% in one year.

Market Cap

23.89T

Enterprise Value

23.63T

Revenue

158.06B

Ranking

n/a

PE Ratio

276.38

Stock Price

447,000.00

Market Cap Chart

Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 23.89T, an increase of 19,814.23%. That is a compound annual growth rate of 63.28%.

Market Cap History

Date	Market Cap	% Change
Sep 26, 2025	23.89T	44.82%
Dec 30, 2024	16.49T	221.05%
Dec 28, 2023	5,137.84B	160.78%
Dec 29, 2022	1,970.17B	-38.41%
Dec 30, 2021	3,198.72B	-36.62%
Dec 30, 2020	5,046.50B	442.81%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	71.17T
Celltrion	39.21T
Yuhan	8,582.33B
SK Biopharmaceuticals	7,948.79B
Peptron	6,470.56B
PharmaResearch	6,005.22B
LigaChem Biosciences	5,185.05B
HLB Co., Ltd.	5,083.92B

Market Cap Rankings